News Focus
News Focus
icon url

Batermere

03/31/17 4:58 PM

#7195 RE: TRUMPFORPRES #7194

Hahaha. And we believe everything you say, TRUMP. NOT!!!
icon url

Honeycomb777

03/31/17 7:49 PM

#7204 RE: TRUMPFORPRES #7194

Trump - those (large) newspaper ads all require customers to call in. They all state there is a limited number on reserve in "their area". I guarantee that they will be showing strong numbers from these nationwide ads, especially with UriVarx and Recalmax as think about who still subcribes to, and reads, the newspapers ? Yes - SENIORS

http://local.postregister.com/places/view/2456/uri_varx.html


https://issuu.com/dmsgroup/docs/09-14-2016.pdf (page A11)
icon url

MarketCap

04/01/17 8:11 PM

#7216 RE: TRUMPFORPRES #7194

Trumpforpres with your opinion on South Korea, I have to strongly disagree. The deal is for a license and distribution agreement. This means J&H of South Korea will be buying $2mm worth of product from INNV annually for the next 10 years. This is not an arbitrary number, it's the contract price.

“We are pleased with the expedited process taken by our partner to secure approval to import and commercialize Zestra® in South Korea and we look forward to shipping our first product to that country this month,”

https://www.otcmarkets.com/stock/INNV/news/Innovus-Pharma-Announces-the-Approval-to-Commercialize-Zestra-reg--in-South-Korea-Through-its-Partner-J-amp-H-Co--LTD?id=150426&b=y

Secondly, I believe you are mistaken as to believing that this deal limits J&H to just South Korea. Here is a description of the company.

www.globalsources.com/si/AS/JH-trading/6008848245836/Homepage.htm

JH trading Co. Ltd,, a South Korea Agent,Distributor,Exporter exporting products to Eastern Europe,North America,Mid East/Africa.